NewGenIVF Group Limited (NASDAQ: NIVF) has entered into a definitive agreement to acquire an additional 3% equity interest in K25.ai for US$7.5 million, increasing its total ownership in the AI-native livestreaming prediction market to 13%. The transaction values K25.ai at US$250 million, marking a significant step up from the US$200 million post-money valuation established during K25.ai’s Series A round earlier this year. This move strengthens NewGen’s position in the high-growth artificial intelligence sector while reinforcing its Nasdaq listing compliance through share issuance.

The US$7.5 million investment will be funded through the issuance of approximately 2.5 million Class A ordinary shares by NewGen. Upon completion, NewGen’s total outstanding shares are expected to rise to approximately 5.9 million, helping maintain a market capitalization above the US$5 million threshold required for ongoing Nasdaq compliance. The deal follows K25.ai’s successful community beta launch and accelerating market traction across Asia-Pacific, validating NewGen’s early strategic conviction in the platform’s convergence of live streaming, creator economies, and real-time prediction markets.

Investment Progression

Alfred Siu Wing Fung, Founder, Chairman and Chief Executive Officer of NewGen, emphasized that the stepped-up valuation reflects confidence in K25.ai’s AI-native approach as it scales. The company noted that K25.ai is transforming passive audiences into active participants by combining live content with AI-powered resolution mechanisms, building infrastructure for next-generation interactive information markets.

What the Numbers Show

The rapid appreciation of K25.ai’s valuation—from US$100 million at NewGen’s initial Pre-A investment to US$250 million today—demonstrates the high volatility and potential upside inherent in early-stage AI ventures. While NewGen’s original US$10 million investment now carries an implied value of US$25 million, representing a US$15 million unrealized gain, this benefit remains non-cash until recognized in financial statements. Investors should note that the carrying value remains subject to impairment risks, as disclosed in forward-looking statements, and reflects market sentiment around K25.ai’s technology rather than operational cash flows from NewGen’s core healthcare or real estate businesses.

NewGenIVF Group operates through multiple segments including NewGenProperty for real estate development in Ras Al Khaimah, United Arab Emirates; NewGenDigital for digital asset solutions; and NewGenSup for health products, alongside its legacy IVF services across Asia.

NewGenIVF Group Limited has executed an agreement for a further US$4 million strategic investment in K25.ai, completing the target company's US$10 million Pre-A round at a US$100 million valuation. This transaction increases NewGen's aggregate ownership interest in K25.ai to 10%, subject to the satisfaction of applicable closing conditions. The expanded stake includes exclusive Asia-Pacific agency rights, deepening NewGen's strategic participation in K25.ai's next phase of growth. Following the share issuances related to this acquisition, NewGen's total outstanding shares now stand at 10,073,535, and its market capitalization reached US$7,631,710 on June 18, 2026.

Management views this market capitalization as representing a substantial discount to the Company’s net asset value of approximately US$25.98 million as of December 31, 2025. The balance sheet has been further strengthened by the Company’s subsequent US$10 million investment in K25.ai. This capital strength follows the Company’s recently announced strategic direction shift, including the definitive investment agreement with K25.ai, an AI-powered live-streaming prediction market platform, and the adoption of a digital assets treasury strategy.

The investment follows NewGen's initial US$2 million investment announced in May 2026 and a subsequent US$4 million investment announced on June 4, 2026. To facilitate this acquisition, NewGenIVF Group Limited issued 3,666,667 new shares. The completion of the Pre-A round provides K25.ai with strategic backing as it moves toward product launch. Concurrently, K25.ai has commenced its Series A fundraising, which is intended to support commercialization, applicable regulatory licensing, and expansion across selected Asian markets.

K25.ai operates as an AI-native livestreaming and watch-to-predict information market platform purpose-built for the Asia-Pacific region. The company is developing a new category of interactive information markets, combining creator-led livestreaming, AI-assisted market creation and resolution, and real-time community participation.

Investment Details

The following table outlines the sequence of investments made by NewGenIVF Group Limited in K25.ai:

Strategic Objectives

With the Pre-A round closed, K25.ai is positioned to accelerate its product launch and regional expansion. The Series A funds will be utilized to drive commercialization efforts and secure necessary regulatory licenses. NewGen's increased equity position and exclusive regional rights align with its strategy to integrate advanced AI-driven platforms within its diversified growth portfolio. NewGen believes it is now well-positioned to meet Nasdaq’s proposed minimum Market Value of Listed Securities (MVLS) threshold of US$5 million.